Navigation Links
Misusing vitamin to foil drug test may be toxic; plus, it doesn't work

Taking excessive doses of a common vitamin in an attempt to defeat drug screening tests may send the user to the hospital—or worse.

Researchers from The Children's Hospital of Philadelphia and The University of Pennsylvania reported on two adults and two adolescents who suffered toxic side effects from taking large amounts of niacin, also known as vitamin B3, in mistaken attempts to foil urine drug tests.

Both adult patients suffered skin irritation, while both adolescents had potentially life-threatening reactions, including liver toxicity and hypoglycemia (low blood sugar), as well as nausea, vomiting and dizziness. One of the teens also had disrupted heart rhythms.

All four patients recovered after treatment in hospital emergency rooms for the adverse effects. The report appeared online in the Annals of Emergency Medicine.

"Testing urine for drugs is becoming increasingly common for job applicants," said study leader Manoj K. Mittal, M.D., a fellow in Emergency Medicine at The Children's Hospital of Philadelphia. "Because niacin is known to affect metabolic processes, there is a completely unfounded claim that it can rapidly clear the body of drugs such as cannabis and cocaine. However, niacin is toxic when taken in large amounts."

Niacin is easily available as an over-the-counter vitamin supplement. As a vitamin, the daily recommended intake is 15 milligrams, but niacin is used in much larger doses to treat vitamin deficiencies and other conditions. "People often assume niacin is completely safe," said Dr. Mittal. "As a water-soluble vitamin, it is easily excreted from the body. However, the body has its limits, and some of these patients took 300 times the daily recommended dose of niacin." Dr. Mittal added that there is a report in the medical literature of a patient who suffered liver failure, requiring a liver transplant, after taking excessive doses of niacin.

Many Internet sites promote the misconc
'"/>

Source:Children's Hospital of Philadelphia


Page: 1 2

Related biology news :

1. Does vitamin C help prevent or treat the common cold? Maybe not, after all.
2. OHSU research shows vitamin C counteracts some negative impacts of smoking on unborn babies
3. Natural vitamin E tocotrienol reaches blood at protective levels
4. Poor athletic performance linked to vitamin deficiency
5. MIT biologists solve vitamin puzzle
6. Cocoa vitamin health benefits could outshine penicillin
7. Fat overrides effects of vitamin C
8. Heavy multivitamin use may be linked to advanced prostate cancer
9. To sea or not to sea: When it comes to salmon sex, size sometimes doesnt matter
10. What the eye doesnt see
11. Study finds evolution doesnt always favor bigger animals
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Misusing vitamin foil drug test may toxic plus doesn work

(Date:8/5/2015)... August 5, 2015 According to ... Management Market by Software, Services, Vertical (BFSI, Airport, IT & ... - Global Forecast to 2020", published by MarketsandMarkets, defines ... globally into various segments. The global PIAM Market is ... $546.2 Million by 2019, at a CAGR of 14.9 ...
(Date:8/5/2015)... VIEW, Calif. , Aug. 5, 2015 ... exhibits continuous growth in applications, penetration into newer sectors, ... after year. The global biosensors space has seen the ... exited the market so far. (Photo - ... Frost & Sullivan, Analysis of the Global Biosensors ...
(Date:8/4/2015)... (NASDAQ: AMRI ) today reported financial and operating results for ... , Second quarter contract revenue of $ 85.2 ... Adjusted contract margins of 26 % , ... in EPS from royalties in the current quarter , ... are very pleased to present another strong financial quarter, with all ...
Breaking Biology News(10 mins):Physical Identity and Access Management Market Worth $546.2 Million by 2019 2Physical Identity and Access Management Market Worth $546.2 Million by 2019 3Physical Identity and Access Management Market Worth $546.2 Million by 2019 4Innovative Biosensors Incite Use in Non-Traditional Applications 2Innovative Biosensors Incite Use in Non-Traditional Applications 3Innovative Biosensors Incite Use in Non-Traditional Applications 4AMRI Announces Second Quarter 2015 Results 2AMRI Announces Second Quarter 2015 Results 3AMRI Announces Second Quarter 2015 Results 4AMRI Announces Second Quarter 2015 Results 5AMRI Announces Second Quarter 2015 Results 6AMRI Announces Second Quarter 2015 Results 7AMRI Announces Second Quarter 2015 Results 8AMRI Announces Second Quarter 2015 Results 9AMRI Announces Second Quarter 2015 Results 10AMRI Announces Second Quarter 2015 Results 11AMRI Announces Second Quarter 2015 Results 12AMRI Announces Second Quarter 2015 Results 13AMRI Announces Second Quarter 2015 Results 14AMRI Announces Second Quarter 2015 Results 15AMRI Announces Second Quarter 2015 Results 16AMRI Announces Second Quarter 2015 Results 17AMRI Announces Second Quarter 2015 Results 18AMRI Announces Second Quarter 2015 Results 19AMRI Announces Second Quarter 2015 Results 20AMRI Announces Second Quarter 2015 Results 21AMRI Announces Second Quarter 2015 Results 22AMRI Announces Second Quarter 2015 Results 23AMRI Announces Second Quarter 2015 Results 24
... of researchers has found new candidate disease proteins ... of Biochemistry and Biophysics at the Perelman School ... PhD, St. Jude Children,s Research Hospital, and colleagues ... Nature that mutations in prion-like segments of ...
... study led by St. Jude Children,s Research Hospital has discovered ... nerve cells in amyotrophic lateral sclerosis (ALS), also known as ... mutation occurred in both genes and led to the abnormal ... essential role in normal RNA functioning and have also been ...
... An international group of researchers has discovered seven ... with increased risk of age-related macular degeneration (AMD), a ... network of international investigators representing 18 research groups, also ... which is published online in Nature Genetics ...
Cached Biology News:Adding to the list of disease-causing proteins in brain disorders 2Adding to the list of disease-causing proteins in brain disorders 32 new genes linked to amyotrophic lateral sclerosis and related disorders 22 new genes linked to amyotrophic lateral sclerosis and related disorders 3International consortium discovers seven new genomic regions associated with AMD 2International consortium discovers seven new genomic regions associated with AMD 3
(Date:8/31/2015)... SHANGHAI , Aug. 31, 2015 ... developing next-generation antibiotics, today announced positive top-line results ... its lead drug candidate MRX-I. MRX-I is an ... such as MRSA and VRE, while offering physicians ... option than currently available oxazolidinone agents. ...
(Date:8/31/2015)... , Aug. 31, 2015 Trimb Healthcare AB ... to acquire YouMedical Group BV ("YouMedical"), a Dutch OTC ... total annual sales of approximately EUR 16 million, with ... "Our ambition is to build a leading ... step toward that goal. YouMedical gives us a stronger ...
(Date:8/31/2015)... ... August 31, 2015 , ... There’s a new treatment ... is the first commercially available new FDA approved system in the last 14 years, ... 92%, the high Amenorrhea (zero bleeding) rate of 66%, the high Patient Satisfaction rate ...
(Date:8/28/2015)... 28, 2015 Research and ... the "Global & USA BioSimilar Market Analysis to ... highly awaited US Biosimilar market will be initiated in ... Zarxio. How will the global market react? Will biosimilars ... biosimilars could save the US economy up to $250 ...
Breaking Biology Technology:MicuRX Reports Positive Top-Line Results In Phase 2 Clinical Trial For Novel Antibiotic MRX-I In Complicated Skin And Soft Tissue Infections 2U.S. FDA Approves Minerva Endometrial Ablation System 2U.S. FDA Approves Minerva Endometrial Ablation System 3Global & USA BioSimilar Market Analysis Report 2015-2021 2Global & USA BioSimilar Market Analysis Report 2015-2021 3
... New Service Helps Customers to Treat More Patients, ... ARAY ), a global leader in the ... begin offering a treatment planning,service to new and ... centers to access a dedicated team of remote ...
... Medical Specialties, a,47-physician oncology practice located in the ... into an agreement to join US Oncology,s,network. Advanced ... in the U.S., "In today,s challenging healthcare ... keep us in the strongest position to continue,delivering ...
... The National Academy of,Sciences (NAS) Council announced ... officer and executive vice president for Monsanto, has,been ... of Science. This,prize is awarded every three years ... significant, beneficial applications in,industry -- in this case, ...
Cached Biology Technology:Accuray Announces New Treatment Planning Service Offering 2Accuray Announces New Treatment Planning Service Offering 3Accuray Announces New Treatment Planning Service Offering 4Advanced Medical Specialties Joins US Oncology Network 2Advanced Medical Specialties Joins US Oncology Network 3National Academy of Sciences Recognizes Monsanto's Chief Technology Officer for Development of Agricultural Biotechnology 2
EDTA, tetrasodium salt, 1 kg. Ethylene diaminetetraacetic acid.Dihydrate. Assay: 99-101% (as is).Risks: 36, 37, 38 ; Safety Precautions: 22, 36, 37. Category: Nucleotides & Enzymes & Biochemicals, Ul...
EDG-1 Western blot control Source: Cell Lysate Application: Western Blotting Control...
...
Kit containing positive control DNA all parts of the HIV-1 genome, HIV-1 negative control DNA, Primers SK38, SK39, SK19...
Biology Products: